{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:47:29Z","timestamp":1790740049366,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmcl.2023.129155","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:08:11Z","timestamp":1675044491000},"page":"129155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis"],"prefix":"10.1016","volume":"82","author":[{"given":"Ken","family":"Nunettsu Asaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Okimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuka","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Amikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129155_b0005","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1038\/ncomms9777","article-title":"The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-\u03baB signalling","volume":"3","author":"Klein","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.bmcl.2023.129155_b0010","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.4161\/cc.10.15.16923","article-title":"From MALT lymphoma to the CBM signalosome: three decades of discovery","volume":"10","author":"Rosebeck","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bmcl.2023.129155_b0015","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1111\/febs.13325","article-title":"MALT1\u2013a universal soldier: multiple strategies to ensure NF-\u03baB activation and target gene expression","volume":"282","author":"Afonina","year":"2015","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.bmcl.2023.129155_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.bmcl.2023.129155_b0025","doi-asserted-by":"crossref","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bmcl.2023.129155_b0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jid.2016.09.031","article-title":"CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis","volume":"137","author":"Van Nuffel","year":"2017","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.bmcl.2023.129155_b0035","doi-asserted-by":"crossref","first-page":"e49237","DOI":"10.15252\/embr.201949237","article-title":"MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice","volume":"21","author":"Van Nuffel","year":"2020","journal-title":"EMBO Reports"},{"key":"10.1016\/j.bmcl.2023.129155_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.bmcl.2023.129155_b0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: Implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.bmcl.2023.129155_b0050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-\u03baB activation","volume":"473","author":"Howes","year":"2016","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.bmcl.2023.129155_b0055","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3389\/fimmu.2018.02239","article-title":"Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease","volume":"16","author":"Israel","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bmcl.2023.129155_b0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.bmcl.2023.129155_b0065","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fimmu.2018.01927","article-title":"Holding All the CARDs: How MALT1 Controls CARMA\/CARD-Dependent Signaling","volume":"30","author":"Juilland","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bmcl.2023.129155_b0070","doi-asserted-by":"crossref","first-page":"914","DOI":"10.15252\/embr.201642109","article-title":"The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes","volume":"17","author":"Afonina","year":"2016","journal-title":"EMBO Reports"},{"key":"10.1016\/j.bmcl.2023.129155_b0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/13543776.2021.1951703","article-title":"A patent review of MALT1 inhibitors (2013-present)","volume":"31","author":"Hamp","year":"2021","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.bmcl.2023.129155_b0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.bmcl.2023.129155_b0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","article-title":"MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo","volume":"22","author":"Fontan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmcl.2023.129155_b0090","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1002\/anie.201304290","article-title":"Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase","volume":"52","author":"Schlauderer","year":"2013","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/j.bmcl.2023.129155_b0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41589-018-0222-1","article-title":"An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient","volume":"15","author":"Quancard","year":"2019","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.bmcl.2023.129155_b0100","doi-asserted-by":"crossref","unstructured":"Ulrike Philippar; Tianbao Lu; Nele Vloemans; Mariette Bekkers; Luc Van Nuffel; Marcello Gaudiano; Katarzyna Wnuk-Lipinska; Bas-jan Van Der Leede; Katie Amssoms; Kristof Kimpe; Bart Medaer; Tony Greway; Yann Abraham; Max Cummings; Emanuele Trella; Greet Vanhoof; Weimei Sun; Jan Willem Thuring; Peter Connolly; Jan Linders; Haopeng Rui; Sriram Balasubramanian; Amy Johnson; John Gerecitano; Jenna Goldberg; James P. Edwards; Yusri Elsayed; Jennifer Smit; Jaqueline Bussolari; Jaqueline Bussolari; Ricardo Attar. Discovery of JNJ-67856633: A novel, first-in-class MALT1 protease inhibitor for the treatment of B cell lymphomas. Cancer Res. 2020; 80: 5690. doi: 10.1158\/1538-7445.AM2020-5690.","DOI":"10.1158\/1538-7445.AM2020-5690"},{"key":"10.1016\/j.bmcl.2023.129155_b0105","article-title":"Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease","volume":"1","author":"Asaba","year":"2021","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.bmcl.2023.129155_b0110","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: A Rational Approach in Drug Design","volume":"96","author":"Patani","year":"1996","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.bmcl.2023.129155_b0115","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmcl.2023.129155_b0120","doi-asserted-by":"crossref","unstructured":"Poindexter GS, Bruce MA, Breitenbucher JG, Higgins MA, Sit SY, Romine JL, Martin SW, Ward SA, McGovern RT, Clarke W, Russell J, Antal-Zimanyi I. Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements. Bioorg Med Chem. 2004 Jan 15;12(2):507-21. doi: 10.1016\/j.bmc.2003.10.016.","DOI":"10.1016\/j.bmc.2003.10.016"},{"key":"10.1016\/j.bmcl.2023.129155_b0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm00217a007","article-title":"Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine","volume":"20","author":"Durant","year":"1977","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmcl.2023.129155_b0130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0223-5234(00)01174-0","article-title":"Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties","volume":"35","author":"Wouters","year":"2000","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmcl.2023.129155_b0135","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1039\/c1cc12439k","article-title":"Thiourea isosteres as anion receptors and transmembrane transporters","volume":"47","author":"Wenzel","year":"2011","journal-title":"Chemical Communications (London)"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:36Z","timestamp":1760773596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"alternative-id":["S0960894X23000331"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129155","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129155"}}